Volpara Health Technologies (ASX: VHT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Volpara Health Technologies Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Volpara Health Technologies (ASX: VHT)
Latest News
Share Gainers
Why Lake Resources, Platinum, Polynovo, and Volpara shares are charging higher
Opinions
10 ASX shares I think are buys for 2023
Opinions
If I was 40 and had never invested, here's how I'd aim to build a $500,000 ASX share portfolio
Healthcare Shares
Why I'd invest in these 3 ASX shares to combat this one inflationary megatrend
Small Cap Shares
3 ASX shares I think are primed to break out in 2023
Opinions
Why I'm buying ASX shares in this once-in-a-lifetime market to try and retire early
Cheap Shares
Ballin' on a budget: The best ASX shares to buy for under $5
Opinions
Here's why I think these ASX shares are top ideas to buy right now
Healthcare Shares
Volpara share price leaps 5% following record cash receipts
Opinions
Why I think these 2 ASX growth shares could keep marching upwards
Share Gainers
This ASX All Ordindaries healthcare share is ripping 17% higher amid a new contract win
Growth Shares
Here's where I'd invest $3,000 into ASX growth shares today
Frequently Asked Questions
-
No, the ASX healthcare share has not yet paid any dividends.
-
Volpara listed on 27 April 2016.
VHT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Volpara Health Technologies
Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.
Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.
Volpara Health Technologies Ltd (ASX: VHT) was removed from the ASX Official List on 22 May 2024.